Paul F. Truex - 31 May 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
31 May 2022
Net transactions value
+$143,795
Form type
4
Filing time
01 Jun 2022, 21:32:38 UTC
Previous filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIST Common Shares Options Exercise $8,978 +8,016 $1.12 8,016 31 May 2022 Direct
transaction MIST Common Shares Options Exercise $69,411 +45,072 +562% $1.54 53,088 31 May 2022 Direct
transaction MIST Common Shares Options Exercise $35,220 +22,870 +43% $1.54 75,958 31 May 2022 Direct
transaction MIST Common Shares Options Exercise $2,187 +822 +1.1% $2.66 76,780 31 May 2022 Direct
transaction MIST Common Shares Purchase $28,000 +5,000 +6.5% $5.60 81,780 31 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Options Exercise $0 -8,016 -100% $0.000000* 0 31 May 2022 Common Shares 8,016 $1.12 Direct F1
transaction MIST Stock Option (right to buy) Options Exercise $0 -45,072 -100% $0.000000* 0 31 May 2022 Common Shares 45,072 $1.54 Direct F1
transaction MIST Stock Option (right to buy) Options Exercise $0 -22,870 -90% $0.000000 2,659 31 May 2022 Common Shares 22,870 $1.54 Direct F2
transaction MIST Stock Option (right to buy) Options Exercise $0 -822 -88% $0.000000 117 31 May 2022 Common Shares 822 $2.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3 Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.